PubMed

Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.

Kolb HJ, Socié G, Duell T, Van Lint MT, Tichelli A, Apperley JF, Nekolla E, Ljungman P, Jacobsen N, van Weel M, Wick R, Weiss M, Prentice HG.

Ann Intern Med. 1999 Nov 16;131(10):738-44.PMID: 10577296 [PubMed - indexed for MEDLINE]Related articlesFree article

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF, Weiss M, Cohen A, Nekolla E, Kolb HJ.

Ann Intern Med. 1997 Feb 1;126(3):184-92.PMID: 9027268 [PubMed - indexed for MEDLINE]Related articlesFree article

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E.

N Engl J Med. 1993 Oct 14;329(16):1152-7.PMID: 8377778 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP.

N Engl J Med. 1999 Jul 1;341(1):14-21.PMID: 10387937 [PubMed - indexed for MEDLINE]Related articlesFree article

Solid cancers after bone marrow transplantation.

Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socíe G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr.

N Engl J Med. 1997 Mar 27;336(13):897-904.PMID: 9070469 [PubMed - indexed for MEDLINE]Related articlesFree article

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M, Ortin M, Freires M, Hale G, Waldmann H, Gordon-Smith EC, Marsh JC.

Biol Blood Marrow Transplant. 2004 Dec;10(12):867-76.PMID: 15570255 [PubMed - indexed for MEDLINE]Related articles

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

Doney K, Leisenring W, Storb R, Appelbaum FR.

Ann Intern Med. 1997 Jan 15;126(2):107-15.PMID: 9005744 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.

Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G.

J Clin Oncol. 2007 Jun 10;25(17):2449-54.PMID: 17557958 [PubMed - indexed for MEDLINE]Related articles

Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.

Min CK, Kim DW, Lee JW, Min WS, Kim CC.

Acta Haematol. 2000;104(4):185-92.PMID: 11279309 [PubMed - indexed for MEDLINE]Related articles

Secondary malignancies after bone marrow transplantation in adults.

Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H.

J Clin Oncol. 1994 Oct;12(10):2187-92.PMID: 7931488 [PubMed - indexed for MEDLINE]Related articles

Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.

Locatelli F, Bruno B, Zecca M, Van-Lint MT, McCann S, Arcese W, Dallorso S, Di Bartolomeo P, Fagioli F, Locasciulli A, Lawler M, Bacigalupo A.

Blood. 2000 Sep 1;96(5):1690-7.PMID: 10961865 [PubMed - indexed for MEDLINE]Related articlesFree article

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

Locatelli F, Zecca M, Rondelli R, Bonetti F, Dini G, Prete A, Messina C, Uderzo C, Ripaldi M, Porta F, Giorgiani G, Giraldi E, Pession A.

Blood. 2000 Mar 1;95(5):1572-9.PMID: 10688810 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.

Castro-Malaspina H, Childs B, Laver J, Shank B, Brochstein J, Gillio A, Flomenberg N, Young J, Boulad F, Black P, et al.

Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):847-54.PMID: 8040033 [PubMed - indexed for MEDLINE]Related articles

De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival.

Wagner JL, Seidel K, Boeckh M, Storb R.

Biol Blood Marrow Transplant. 2000;6(6):633-9.PMID: 11128814 [PubMed - indexed for MEDLINE]Related articles

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.

Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM.

J Clin Oncol. 2000 Jan;18(2):348-57.PMID: 10637249 [PubMed - indexed for MEDLINE]Related articles

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.

Arranz R, Conde E, Rodriguez-Salvanés F, Pajuelo FJ, Cabrera R, Sanz MA, Petit J, Bueno J, Maldonado J, Odriozola J, Conde JG, Brunet S, Carreras E, Iriondo A, Fernández-Rañada JM, Marín P; Subcomité de Aplasia Medular del Grupo Español de Trasplante Hemopoyético.

Bone Marrow Transplant. 2002 Feb;29(3):205-11.PMID: 11859392 [PubMed - indexed for MEDLINE]Related articlesFree article

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R.

Blood. 1996 Jan 1;87(1):386-92.PMID: 8547667 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.

Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ.

Biol Blood Marrow Transplant. 2002;8(5):261-7.PMID: 12064363 [PubMed - indexed for MEDLINE]Related articles

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.

Bacigalupo A, Oneto R, Bruno B, Socié G, Passweg J, Locasciulli A, Van Lint MT, Tichelli A, McCann S, Marsh J, Ljungman P, Hows J, Marin P, Schrezenmeier H.

Acta Haematol. 2000;103(1):19-25.PMID: 10705155 [PubMed - indexed for MEDLINE]Related articles

Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.

Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A, van Lint M, Gratwohl A, Kolb HJ.

Bone Marrow Transplant. 1996 Jun;17(6):1105-11.PMID: 8807122 [PubMed - indexed for MEDLINE]Related articles